Drawing for RELZIQ

USPTO serial 85676529

RELZIQ

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
TOOLEY, DAVID E
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RELZIQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert E. Lee, Jr.

ROBERT E. LEE, JR. ELI LILLY AND COMPANYLILLY CORPORATE CENTERINDIANAPOLIS, IN 46285-0001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Veterinary preparations, namely, vaccines, antimicrobials, antivirals, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, non-infectious and metabolic diseases in animals; medicated feed and water additives for animals; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; veterinary hormone preparations and hormone preparation implants for animals; Veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; diagnostic agents, tests, and preparations and substances to identify pathogens and residues of biological interest for veterinary use; Veterinary preparations for companion animals, namely, to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders, nonsurgical sterilization; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely, vaccines for companion animalsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 2, 2013MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
May 2, 2013ABN5ABANDONMENT - AFTER PUBLICATION—
Apr 30, 2013EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jan 31, 2013ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 1, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 1, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 23, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 23, 2012ALIEASSIGNED TO LIE—
Nov 5, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 5, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Nov 5, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 5, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 5, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 31, 2012DOCKASSIGNED TO EXAMINER—
Jul 20, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 17, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance